Recent Quotes

My Watchlist

Indicators

Atossa Therapeutics Inc (NQ: ATOS )

1.420 +0.040 (+2.90%)

Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	592,727
Open	1.380
Bid (Size)	1.400 (53)
Ask (Size)	1.440 (48)
Prev. Close	1.380
Today's Range	1.380 - 1.440
52wk Range	0.6200 - 2.310
Shares Outstanding	125,785,200
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Domino's Pizza To $510? Here Are 10 Top Analyst Forecasts For Wednesday

September 11, 2024

Via Benzinga

ATOS Stock Earnings: Atossa Therapeutics Beats EPS for Q2 2024

August 12, 2024

ATOS stock results show that Atossa Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Performance

YTD	+51.87%	+51.87%
1 Month	-3.40%	-3.40%
3 Month	+16.39%	+16.39%
6 Month	-14.46%	-14.46%
1 Year	+103.44%	+103.44%

More News

3 Dirt-Cheap Drug Developers With Blockbuster Potential

July 11, 2024

Via InvestorPlace

3 Penny Stock Moonshots with 300%+ Upside Potential by 2025

July 03, 2024

Via InvestorPlace

Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar

June 07, 2024

Via InvestorPlace

MicroMarvel - Atossa Therapeutics

April 06, 2024

Via Talk Markets

Atossa Therapeutics backing Endoxifen in the fight against breast cancer

August 23, 2023

Via News Direct

3 Must-Buy Biotech Stocks Before the Summer Rally Kicks Off

May 20, 2024

Via InvestorPlace

Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024

May 17, 2024

Via InvestorPlace

ATOS Stock Earnings: Atossa Therapeutics Beats EPS for Q1 2024

May 13, 2024

Via InvestorPlace

Shhh! 3 Secret Penny Stocks Flying Below Wall Street’s Radar

May 09, 2024

Via InvestorPlace

ATOS Stock Earnings: Atossa Therapeutics Misses EPS for Q4 2023

April 01, 2024

Via InvestorPlace

Catalyst Countdown: 3 Biotech Stocks With Upcoming News That Could Move the Market

January 16, 2024

Via InvestorPlace

This Drug Developer Is Dedicated To "Transforming The Breast Cancer Paradigm"

October 24, 2023

Via Benzinga

Approximately 30% Of Newly Diagnosed Cancers In Women Will Be Breast Cancers - Atossa Therapeutics Has A Promising Drug To Help With Prevention And Treatment

September 18, 2023

Via ACCESSWIRE

Approximately 30% Of Newly Diagnosed Cancers In Women Will Be Breast Cancers – Atossa Therapeutics Has A Promising Drug To Help With Prevention And Treatment

September 15, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session

September 08, 2023

Via Benzinga

Breast Cancer-Focused Atossa Therapeutics Can Possibly Change Treatment Paradigm: Analyst

September 08, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session

September 08, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2023

September 08, 2023

Via Benzinga

Could Anixa Biosciences (NASDAQ: ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?

August 09, 2023

Via Benzinga

50% Of Women Have Elevated Breast Density, Which Significantly Decreases the Effectiveness of Mammography - Atossa Therapeutics Is Looking To Ensure Earlier, Accurate Diagnosis

July 12, 2023

Via ACCESSWIRE

50% Of Women Have Elevated Breast Density, Which Significantly Decreases The Effectiveness Of Mammography – Atossa Therapeutics Is Looking To Ensure Earlier, Accurate Diagnosis

July 11, 2023

Via Benzinga

3 Penny Stocks to Make Your ‘Get Rich’ Dreams Come True

July 06, 2023

Via InvestorPlace

3 Penny Stocks Set to Pass the $5 Mark Soon

June 23, 2023

Via InvestorPlace

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.